Application of benzodifuranone compound in treatment of intractable epilepsy

A technology of benzodifuranone and refractory epilepsy, which is applied in the field of medicine, can solve problems such as limitations and high costs, and achieve an obvious synergistic effect

Active Publication Date: 2021-11-23
AFFILIATED HOSPITAL OF JINING MEDICAL UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, the treatment of epilepsy is mainly based on drugs. However, for patients with refracto...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of benzodifuranone compound in treatment of intractable epilepsy
  • Application of benzodifuranone compound in treatment of intractable epilepsy
  • Application of benzodifuranone compound in treatment of intractable epilepsy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] Example 1 Effect test of Aspeterreurone A on cell model of intractable epilepsy

[0016] The hippocampal neurons cultured to the 7th day were randomly divided into normal control group (group C), model group (group M), model+0.1μMAtrA group (AtrA1 group), model+1μMAtrA group (AtrA2 group), model+10μMAtrA group group (AtrA3 group), model+100 μM AtrA group (AtrA4 group). In the normal control group, the medium was changed to normal extracellular fluid for 3 hours and then returned to 2 mL of maintenance medium culture. In the model group, the medium was changed to magnesium-free extracellular fluid after 3 hours of culture and then returned to 2 mL of maintenance medium culture. Magnesium extracellular fluid was cultured for 3 hours and then restored to maintenance medium containing final concentrations of 0.1 μM, 1 μM, 10 μM, and 100 μM Speterreurone A, and the six-well plate was returned to the incubator for 24 hours of further culture.

[0017] Maintenance medium comp...

Embodiment 2

[0022] Example 2: Study on the curative effect of Aspeterreurone A on lithium-pilocarpine refractory epilepsy rats

[0023]Pilocarpine is a muscarinic receptor agonist, which can activate cholinergic neurons and disrupt the balance of glutamate and γ-aminobutyric acid. Lithium chloride can enhance the function of pilocarpine. Temporal lobe epilepsy is the most common treatment-resistant epilepsy, and the lithium-pilocarpine model is often used to study temporal lobe epilepsy. The pathological features of the lithium-pilocarpine model include inflammation, glial cell proliferation, massive loss of neurons, and mossy fiber sprouting, which are similar to the neuropathological features of temporal lobe epilepsy. Therefore, the present invention selects the lithium-pilocarpine rat model for pharmacodynamic experimental research.

[0024] Healthy male SD rats with body weight in the range of 180-220g. After the experiment started, the lithium chloride-pilocarpine hydrochloride r...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses application of a benzodifuranone compound in preparation of medicines for treating intractable epilepsy, and belongs to the technical field of medicines. According to the application, the benzodifuranone compound is used for treating epilepsy for the first time, and particularly a new candidate drug is provided for treatment of intractable epilepsy. In addition, the invention further provides a compound medicine combining the benzodifuranone compound and sodium valproate, and the benzodifuranone compound and the sodium valproate have an obvious synergistic effect in treatment of intractable epilepsy diseases.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to the application of a benzodifuranone compound in the preparation of drugs for treating refractory epilepsy. Background technique [0002] Epilepsy is a common neurological disease. It is a syndrome of chronic recurrent transient brain dysfunction, characterized by seizures caused by abnormal discharge of brain neurons. Most patients can be well controlled with anti-epileptic drugs (Anti-Epileptic Drugs), but more than 30% of patients are ineffective to the existing anti-epileptic drugs, which is called refractory epilepsy (Refractory Epilepsy, RE). The International League Against Epilepsy defines RE as epilepsy that cannot control the onset of seizures after selecting ≥ 2 tolerable antiepileptic drugs in sufficient doses and courses of treatment to reach an effective concentration in the body. In China, the diagnosis of RE refers to the absence of central nervous s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/365A61P25/08A61K31/19
CPCA61K31/365A61K31/19A61P25/08A61K2300/00Y02A50/30
Inventor 邢春叶孙鹏范欣
Owner AFFILIATED HOSPITAL OF JINING MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap